Ovarian cancer overview: Difference between revisions
Hudakarman (talk | contribs) |
Hudakarman (talk | contribs) No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
'''[[Ovarian cancer]]''' is a [[malignant]] [[tumor]], of any [[histology]], on or within an [[ovary]]. Because many [[ovarian]] [[tumors]] are [[benign]] but have the potential to become [[malignant]], a | '''[[Ovarian cancer]]''' is a [[malignant]] [[tumor]], of any [[histology]], on or within an [[ovary]]. Because many [[ovarian]] [[tumors]] are [[benign]] but have the potential to become [[malignant]], a broad definition of [[Ovarian cancer|ovarian cance]][[Ovarian cancer|r]] includes all [[Ovarian cancer|ovarian tumors,]] [[malignant]] and [[benign]]. [[Epithelial]] [[ovarian carcinoma]] is considered as one entity that includes [[ovarian cancer]], [[fallopian tube cancer]], and [[Peritoneal carcinomatosis|peritoneal cancer]] because they share similar behavior and clinical characteristics. Usually they are [[Diagnosis|diagnosed]] as an [[ovarian mass]] (primary [[ovarian cancer]]) with tubal extension and/or [[peritoneal]] [[metastasis]] and in the absence of [[ovarian mass]], [[Peritoneal carcinomatosis|peritoneal carcinoma]]. The first link between many [[Ovarian cancer|ovarian]] and [[breast cancers]] and the single [[gene]] on [[chromosome 17]] was described first by Dr. King in 1990. Dr. King named the [[genes]] as [[BRCA1]] and [[BRCA2]] in 1991 and 1994 consequently. Evidence have shown that epithelial [[ovarian cancer]] has three possible sites of origin, tubal, and other Mullerian epithelial pelvic origins as [[endometriosis]] or endosalpingiosis. The understanding of the [[pathogenesis]] of [[ovarian cancer]] has been progressed throughout the years. The types of [[ovarian cancer]] are classified based on the origin of the primary [[mass]] and based on the [[histological]] findings. [[Neoplasms]] with ovarian [[origin]] are described [[histologically]] as [[Endometrioid tumor|endometrioid]], [[mucinous]], [[clear cell]], low-grade serous [[carcinomas]] and borderline [[neoplasms]]. Two hypothesis developed regarding the origin of primary [[ovarian cancer]], [[endometriosis]] or Müllerian inclusion cysts. [[Ovarian cancer]] causes are not fully known but there are some theories suggest that [[inflammatory]] [[cytokines]] play a role in transforming the [[ovarian]] epithelium with repeated [[Ovulation|ovulations]]. Another [[theory]] relates the ovarian epithelium injury to the direct effect of persistent [[gonadotrophin]] release. [[Risk factors]] of [[ovarian cancer]] include [[age]], [[hormonal]] and [[reproductive]] factors as [[infertility]], genetic factors as [[BRCA]] [[gene]] [[mutations]] and [[Lynch syndrome]], and [[Environmental factor|environmental]] factors as [[smoking]] and [[asbestos]]. [[Ovarian cancer]] is unfortunately usually [[Diagnosis|diagnosed]] in its late stages. [[Symptoms]] and [[signs]] if present can include palpable [[adnexal mass]], [[bloating]], [[urinary urgency]] and [[frequency]], [[early satiety]], [[pelvic]] or [[abdominal pain]], or [[weight loss]]. Definitive [[diagnosis]] can only be made by the [[surgical]] [[exploration]] of the [[tumor]], it [[origin]] and extent, [[metastasis]], and its [[histological]] characteristics. [[Ovarian cancer]] treatment depends on [[Cancer staging|stage]] and [[Grading (tumors)|grade]] [[classification]] of the tumor and also on the functioning level of the patient. Management can be only [[surgery]] (stage IA & IB), [[adjuvant chemotherapy]] (stages with high risk features), or [[neoadjuvant chemotherapy]] if the [[tumor]] is unresectable or the patient is in poor condition. [[Drugs]] that are used for [[ovarian cancer]] are [[doxorubicin]], [[paclitaxel]], and [[bevacizumab]]. [[Gemcitabine]] and [[topotecan]] are also used for recurrent cases. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 13:39, 30 July 2019
|
Ovarian cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ovarian cancer overview On the Web |
|
American Roentgen Ray Society Images of Ovarian cancer overview |
|
Risk calculators and risk factors for Ovarian cancer overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.
Overview
Ovarian cancer is a malignant tumor, of any histology, on or within an ovary. Because many ovarian tumors are benign but have the potential to become malignant, a broad definition of ovarian cancer includes all ovarian tumors, malignant and benign. Epithelial ovarian carcinoma is considered as one entity that includes ovarian cancer, fallopian tube cancer, and peritoneal cancer because they share similar behavior and clinical characteristics. Usually they are diagnosed as an ovarian mass (primary ovarian cancer) with tubal extension and/or peritoneal metastasis and in the absence of ovarian mass, peritoneal carcinoma. The first link between many ovarian and breast cancers and the single gene on chromosome 17 was described first by Dr. King in 1990. Dr. King named the genes as BRCA1 and BRCA2 in 1991 and 1994 consequently. Evidence have shown that epithelial ovarian cancer has three possible sites of origin, tubal, and other Mullerian epithelial pelvic origins as endometriosis or endosalpingiosis. The understanding of the pathogenesis of ovarian cancer has been progressed throughout the years. The types of ovarian cancer are classified based on the origin of the primary mass and based on the histological findings. Neoplasms with ovarian origin are described histologically as endometrioid, mucinous, clear cell, low-grade serous carcinomas and borderline neoplasms. Two hypothesis developed regarding the origin of primary ovarian cancer, endometriosis or Müllerian inclusion cysts. Ovarian cancer causes are not fully known but there are some theories suggest that inflammatory cytokines play a role in transforming the ovarian epithelium with repeated ovulations. Another theory relates the ovarian epithelium injury to the direct effect of persistent gonadotrophin release. Risk factors of ovarian cancer include age, hormonal and reproductive factors as infertility, genetic factors as BRCA gene mutations and Lynch syndrome, and environmental factors as smoking and asbestos. Ovarian cancer is unfortunately usually diagnosed in its late stages. Symptoms and signs if present can include palpable adnexal mass, bloating, urinary urgency and frequency, early satiety, pelvic or abdominal pain, or weight loss. Definitive diagnosis can only be made by the surgical exploration of the tumor, it origin and extent, metastasis, and its histological characteristics. Ovarian cancer treatment depends on stage and grade classification of the tumor and also on the functioning level of the patient. Management can be only surgery (stage IA & IB), adjuvant chemotherapy (stages with high risk features), or neoadjuvant chemotherapy if the tumor is unresectable or the patient is in poor condition. Drugs that are used for ovarian cancer are doxorubicin, paclitaxel, and bevacizumab. Gemcitabine and topotecan are also used for recurrent cases.